Nerissa Kreher's Net Worth
$1.48 Million
Who is Nerissa Kreher?
Nerissa Kreher has an estimated net worth of $1.48 Million. This is based on reported shares across multiple companies, which include Entrada Therapeutics, Inc., Rezolute, Inc., and AVROBIO, Inc..
SEC CIK
Nerissa Kreher's CIK is 0001741850
Past Insider Trading and Trends
2022 was Nerissa Kreher's most active year for acquiring shares with 15 total transactions. Nerissa Kreher's most active month to acquire stocks was the month of August. 2022 was Nerissa Kreher's most active year for disposing of shares, totalling 25 transactions. Nerissa Kreher's most active month to dispose stocks was the month of August. 2023 saw Nerissa Kreher paying a total of $56,091.00 for 169,510 shares, this is the most they've acquired in one year. In 2023 Nerissa Kreher cashed out on 57,299 shares for a total of $440,334.83, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Entrada Therapeutics, Inc. (TRDA) Snapshot price: $14.8
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +47.57% | 12.91K |
$13.78 | -$17,821.22 | 40.04K |
Sep 1 - Sep 6
| |||
Form 4
|
—
|
0
|
$8.43 | -$338,128.20 | 27.13K |
Aug 2 - Aug 4
| |||
Form 4/A
| +109.82% | 14.2K |
—
|
—
| 27.13K |
Mar 1
| |||
Form 4
| +166.37% | 25.81K |
$10.94 | -$28,294.43 | 41.33K |
Scheduled
|
Mar 1 - Mar 2
| ||
Form 4
| -25.10% | -5.20K |
$13.45 | -$69,931.68 | 15.52K |
Scheduled
|
Dec 30
| ||
Form 4
|
—
|
0
|
$11.69 | -$249,248.70 | 20.72K |
Scheduled
|
Oct 25 - Oct 26
| ||
Form 4
|
—
|
0
|
$8.70 | -$113,382.85 | 20.72K |
Scheduled
|
Sep 26 - Sep 28
| ||
Form 4
|
—
|
0
|
$8.59 | -$55,572.09 | 20.72K |
Scheduled
|
Sep 21 - Sep 23
| ||
Form 4
|
—
|
0
|
$8.56 | -$1,368.82 | 20.72K |
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
$8.61 | -$26,287.18 | 20.72K |
Scheduled
|
Sep 8 - Sep 9
| ||
Form 4
| +33.27% | 5.17K |
—
|
—
| 20.72K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +198.92% | 10.34K |
—
|
—
| 15.54K |
Mar 1
| |||
Form 4
|
∞
| 5.2K |
$2.10 | $10,920.00 | 5.2K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rezolute, Inc. (RZLT) Snapshot price: $4.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVROBIO, Inc. (AVRO) No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.94K |
$0.91 | $2,677.22 | 2.94K |
Oct 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||